Diagnosis and Management of Left Atrium Appendage Thrombosis in Atrial Fibrillation Patients Undergoing Cardioversion(6 visite) Melillo E, Palmiero G, Ferro A, Mocavero PE, Monda V, Ascione L
Medicina (ISSN: 1010-660xlinking), 2019 Aug 21; 55(9): N/D-N/D.
Tipo di articolo: Journal Article, Review
Impact factor: 1.467, Impact factor a 5 anni: 0
Url: Non disponibile.
Parole chiave: Atrial Fibrillation, Cardioversion, Left Atrial Appendage Thrombosis, Oral Anticoagulation Therapy, Transesophageal Echocardiography
*** IBB - CNR *** Department of Cardiology, AO dei Colli, Monaldi Hospital, 80131 Naples, Italy. firstname.lastname@example.org. Institute of Biostructure and Bioimaging, National Council Research, 80131 Naples, Italy. Anesthesiology and Intensive Care Unit, AO dei Colli, Monaldi Hospital, 80131 Naples, Italy.
Atrial fibrillation is the most common cardiac arrhythmia and is associated with an increased risk of stroke and thromboembolic complications. A rhythm control strategy with both electrical and pharmacological cardioversion is recommended for patients with symptomatic atrial fibrillation. Anticoagulant therapy for 3-4 weeks prior to cardioversion is recommended in order to avoid thromboembolic events deriving from restoring sinus rhythm. Transesophageal echocardiography has a pivotal role in this setting, excluding the presence of left atrial appendage thrombus before cardioversion. The aim of this review is to discuss the epidemiology and risk factors for left atrial appendage thrombosis, the role of echocardiography in the decision making before cardioversion, and the efficacy of different anticoagulant regimens on the detection and treatment of left atrial appendage thrombosis.<br>